article thumbnail

STAT Virtual Event: The Next Frontier of Drug Pricing Reform

STAT

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Pharmacy benefit managers are intermediaries that are supposed to negotiate lower drug costs. But does the system work for patients? And how can we fix it when it doesn’t? Read the rest…

article thumbnail

STAT+: As Medicare drug pricing negotiations begin, AstraZeneca stays mum on government’s offer

STAT

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Medicare chief on the new drug price negotiation program’s operations, hiring, and timelines

STAT

WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive program will start to negotiate drug prices — let alone the substantive ones, Medicare chief Meena Seshamani said at a STAT event Tuesday.

article thumbnail

STAT Virtual Event: The State of Biosimilars: What to Watch

STAT

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

article thumbnail

STAT+: Pharmalittle: We’re reading about a FDA AI tool, mRNA as a political reject, and more

STAT

In the public announcement, the agency said the tool can “summarize adverse events to support safety profile assessments, perform faster label comparisons, and generate code to help develop databases for nonclinical applications.” The contents of the proposal will not be public during the review period.

article thumbnail

Cartesian’s CAR-T may help autoimmune patients long term

STAT

I’m writing to you from San Diego, where STAT held an event during the American Academy of Neurology annual meeting this past weekend. We’ll get into a highlight from the event below, along with all the other biotech news today.   Sign up  to get our biotech newsletter in your inbox. Good morning.

article thumbnail

CMS Patient Engagement Roundtable: Medicare Drug Pricing

Putting Patients First Blog

CMS Patient Engagement Roundtable: Medicare Drug Pricing Event Time: 2:00 - 4:30 p.m. ET Event Location: Private (Invitation Only) The National Health Council (NHC) is pleased to host a roundtable discussion with the Centers for Medicare & Medicaid Services (CMS) on Monday, June 30 , from 2:00 to 4:30 p.m.